MX2016006103A - Suplemento a base de teacrina y metodo de uso del mismo. - Google Patents

Suplemento a base de teacrina y metodo de uso del mismo.

Info

Publication number
MX2016006103A
MX2016006103A MX2016006103A MX2016006103A MX2016006103A MX 2016006103 A MX2016006103 A MX 2016006103A MX 2016006103 A MX2016006103 A MX 2016006103A MX 2016006103 A MX2016006103 A MX 2016006103A MX 2016006103 A MX2016006103 A MX 2016006103A
Authority
MX
Mexico
Prior art keywords
theacrine
based supplement
supplement
mood
anxiety
Prior art date
Application number
MX2016006103A
Other languages
English (en)
Other versions
MX373132B (es
Inventor
l lopez Hector
WELLS Shawn
N Ziegenfuss Tim
Original Assignee
Ortho-Nutra Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Nutra Llc filed Critical Ortho-Nutra Llc
Publication of MX2016006103A publication Critical patent/MX2016006103A/es
Publication of MX373132B publication Critical patent/MX373132B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Un suplemento dietético humano comprende teacrina y opcionalmente otros compuestos que modulan los efectos de la teacrina. Algunos usos para el suplemento que contiene teacrina incluyen la mejoría de por lo menos uno de los siguientes conceptos; humor, energía, foco, concentración o deseo sexual o una reducción de por lo menos uno de los siguientes conceptos: ansiedad o fatiga.
MX2016006103A 2013-11-12 2014-11-12 Suplemento a base de teacrina y método de uso del mismo. MX373132B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361903362P 2013-11-12 2013-11-12
PCT/US2014/065289 WO2015073576A1 (en) 2013-11-12 2014-11-12 Theacrine-based supplement and method of use thereof

Publications (2)

Publication Number Publication Date
MX2016006103A true MX2016006103A (es) 2017-07-27
MX373132B MX373132B (es) 2020-05-25

Family

ID=53043980

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006103A MX373132B (es) 2013-11-12 2014-11-12 Suplemento a base de teacrina y método de uso del mismo.

Country Status (8)

Country Link
US (1) US10272091B2 (es)
EP (1) EP3068240A4 (es)
CN (1) CN105992521A (es)
AU (3) AU2014348672A1 (es)
BR (1) BR112016010422B1 (es)
CA (1) CA2929666C (es)
MX (1) MX373132B (es)
WO (1) WO2015073576A1 (es)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11583534B2 (en) 2013-11-12 2023-02-21 Ortho-Nutra, Llc Enhanced caffeinated beverage composition
US10398701B2 (en) 2013-11-12 2019-09-03 Ortho-Nutra, Llc Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine
CN106715454B (zh) 2014-07-24 2020-06-16 格雷斯公司 烟酰胺核苷的结晶形式
CA2978069C (en) 2015-03-09 2021-10-12 W.R. Grace & Co.-Conn. Crystalline form of nicotinamide riboside
AU2016302005B2 (en) 2015-08-05 2021-03-04 Metro International Biotech, Llc Nicotinamide mononucleotide derivatives and their uses
WO2017030167A1 (ja) * 2015-08-18 2017-02-23 レジリオ株式会社 神経回路網の再構築・賦活剤
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
US10980764B1 (en) 2016-02-01 2021-04-20 University Of South Florida Exogenous ketone supplements for reducing anxiety-related behavior
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US20230346721A1 (en) 2018-04-18 2023-11-02 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12521378B2 (en) 2016-04-19 2026-01-13 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US12533346B2 (en) 2016-04-19 2026-01-27 Axcess Global Sciences, Llc Administration of berberine metabolites
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
WO2018020491A1 (en) * 2016-07-28 2018-02-01 Trinutra Ltd. SYNERGISTIC COMBINATIONS OF CAFFEINE, GINKGO BILOBA AND β--PHENYLETHYLAMINE
IT201600124013A1 (it) * 2016-12-06 2018-06-06 Solarpharm Srl Prodotto alimentare a base di astaxantina
WO2018112475A1 (en) * 2016-12-16 2018-06-21 Hempep, Inc. Energy compositions and methods
MX392245B (es) * 2017-05-19 2025-03-21 Ortho Nutra Llc Suplemento a base de teacrina y método de uso del mismo en una combinación sinérgica con cafeína.
US11464756B1 (en) 2017-05-19 2022-10-11 Jerry Darm Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11414407B2 (en) 2017-12-22 2022-08-16 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
WO2019152416A1 (en) 2018-01-30 2019-08-08 Metro International Biotech, Llc Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
US10820617B1 (en) * 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement
WO2019200132A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US20210212936A1 (en) 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation
CN109043269A (zh) * 2018-07-10 2018-12-21 鲁东大学 一种含有苦茶碱的固体饮料
CN109350622A (zh) * 2018-10-17 2019-02-19 深圳市龙格生技术有限公司 烟酰胺核糖及其衍生物与吡咯喹啉醌及其钠盐的组合工艺
US10618927B1 (en) 2019-03-22 2020-04-14 Metro International Biotech, Llc Compositions and methods for modulation of nicotinamide adenine dinucleotide
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11033553B2 (en) * 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US20210100266A1 (en) * 2019-10-03 2021-04-08 Phoenix Energy LLC Energy supplement compositions
CA3166354A1 (en) * 2019-12-30 2021-07-08 Ortho-Nutra, Llc Enhanced caffeinated beverage composition
US11541092B2 (en) * 2020-04-08 2023-01-03 Libby and Co. LLC Composition for increasing sexual desire or pleasure
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
IL308577A (en) 2021-05-27 2024-01-01 Metro Int Biotech Llc Crystalline solids of nicotinic acid mononucleotides and their esters and methods for their preparation and use
CN113813263B (zh) * 2021-09-15 2023-02-24 暨南大学附属第一医院（广州华侨医院） 苦茶碱在制备抗皮肤组织光损伤的产品中的应用
GR20230100637A (el) * 2023-07-31 2025-02-11 Ευαγγελος Αριστειδη Βαμβακουσης Παρασκευασμα ενεργειακου ροφηματος που δημιουργει ευεξια, ενεργεια και καλη διαθεση
US12156878B1 (en) * 2023-12-23 2024-12-03 Safety Shot, Inc. Compositions and methods for minimizing effects of alcohol intoxication

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608852A1 (de) * 1986-03-17 1987-09-24 Henkel Kgaa Sebosuppressive zubereitungen
RU2392836C2 (ru) * 2004-12-08 2010-06-27 Унилевер Н.В. Потребительский продукт для улучшения умственной деятельности
CN1317281C (zh) * 2004-12-10 2007-05-23 暨南大学 天然1，3，7，9－四甲基尿酸的生产工艺
JP4807563B2 (ja) * 2005-12-06 2011-11-02 株式会社 伊藤園 容器詰め飲料及びその製造方法
BRPI0819070B1 (pt) * 2007-11-16 2023-12-12 International Ip Holdings Llc Composição energética comestível
CN101289448B (zh) * 2008-06-18 2010-06-09 中山大学 1,3,7,9-四甲基尿酸的制备方法
CN101543498B (zh) * 2009-05-05 2011-05-04 中山大学 苦茶碱在制备消炎镇痛药物中的应用
US9468645B2 (en) 2014-02-25 2016-10-18 Jho Intellectual Property Holdings, Llc Highly soluble purine bioactive compounds and compositions thereof

Also Published As

Publication number Publication date
BR112016010422B1 (pt) 2021-08-31
AU2021266209B2 (en) 2023-12-21
MX373132B (es) 2020-05-25
CA2929666A1 (en) 2015-05-21
AU2021266209A1 (en) 2021-12-02
AU2014348672A1 (en) 2016-06-02
CN105992521A (zh) 2016-10-05
US10272091B2 (en) 2019-04-30
CA2929666C (en) 2023-08-01
EP3068240A4 (en) 2017-06-14
US20150132280A1 (en) 2015-05-14
AU2020200966A1 (en) 2020-02-27
BR112016010422A8 (pt) 2020-04-14
EP3068240A1 (en) 2016-09-21
WO2015073576A1 (en) 2015-05-21

Similar Documents

Publication Publication Date Title
MX2016006103A (es) Suplemento a base de teacrina y metodo de uso del mismo.
MY191169A (en) Anti-fcrh5 antibodies
MX2016003129A (es) Terapia de combinacion de anticuerpos contra el csf-1r humano y anticuerpos contralel pd-l1 humano.
MX2015014500A (es) Terapia de combinacion de anticuerpos contra csf-1r y agonista de tlr9.
IL239754A0 (en) A power source and controller for operating an implantable blood pump
CL2016000354A1 (es) Modulación de la inmunidad tumoral
PH12015501954A1 (en) Anti-b7-h4 antibodies and immunoconjugates
IL238516A0 (en) System and methods for creating curved paths through bone and modulating nerves within the bone
MX2015012326A (es) Anticuerpos anti-crth2 y su uso.
PH12014502601A1 (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
JO3343B1 (ar) أحماض 5- أمينوتتراهيدروكوينولين-2- كربوكسيليك جديدة واستخدامها
GB201309491D0 (en) Thermostimulation apparatus
EA201491617A1 (ru) Соединения для лечения спинальной мышечной атрофии
AU351617S (en) Breathing apparatus
AP2014008093A0 (en) System, method and device for providing a stable power source without the use of direct connection to an AC or DC source
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
MX2015012428A (es) Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios.
AU350280S (en) Apparatus for skin treatment
PH12013501479A1 (en) Small hydropower generation apparatus and method of controlling the same
IN2015DN01524A (es)
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
MX381841B (es) Anticuerpos anti-jagged y métodos de uso.
AU350279S (en) An applicator for an apparatus for skin treatment
AU350271S (en) An applicator for an apparatus for skin treatment
MX2019014090A (es) Métodos para el tratamiento de la reservoritis crónica.

Legal Events

Date Code Title Description
FG Grant or registration